12K views · 256 reactions | The mRNA-1273 SARS-CoV-2 vaccine had high short-term efficacy, but its medium-term efficacy and safety are not known. https://nej.md/2YfXzla | The New England Journal of Medicine | Facebook

25K views · 298 shares | The country's 'first' indigenous COVID-19 vaccine COVAXIN, developed by city-based Bharat Biotech in collaboration with ICMR and NIV, has got the nod for human clinical trials from the Drug Controller General of India, the company said on Monday. The Phase I and Phase II clinical trials of the vaccine for SARS-CoV-2, approved after pre-clinical studies demonstrated safety and immune response, would start across the country next month. | News18 | Facebook

#FrontlineTonight | Ayon sa mga pag-aaral, mas epektibo panlaban sa maraming SARS-CoV-2 variant ang Russian vaccine na Sputnik V. Mas napaparami din nito ang antibodies sa mga taong tinamaan na ng #COVID19. For more latest stories, visit us at www.news5.com.ph | News5